SCHERING DELIVERS $18 MIL TO MESSNER

By Published on .

Most Popular
Schering-Plough HealthCare Products shifted over $18 million in over-the-counter drug brand advertising from its agency of approximately 30 years, Warwick Baker & O'Neill, to Messner Vetere Berger McNamee Schmetterer/

Euro RSCG, both New York.

The company in a statement said "the consolidation is consistent with our strategic goal of accelerating growth through focus and efficiency."

Warwick is now off the roster.

The shift involves Drixoral, Chlor-Trimeton, Coricidin, Di-Gel, Tinactin, Lotrimin AF and Gyne-Lotrimin brands.

Messner Vetere already had the Dr. Scholl's and Afrin brands.

In this article: